News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,716 Results
Type
Article (69839)
Company Profile (737)
Press Release (678140)
Section
Business (205127)
Career Advice (3462)
Deals (35926)
Drug Delivery (119)
Drug Development (85817)
Employer Resources (179)
FDA (17084)
Job Trends (16237)
News (354339)
Policy (34992)
Tag
Academia (2960)
Alliances (51279)
Alzheimer's disease (1366)
Approvals (17022)
Artificial intelligence (165)
Bankruptcy (332)
Best Places to Work (12537)
Biotechnology (511)
Breast cancer (202)
Cancer (1493)
Cardiovascular disease (123)
Career advice (2922)
Cell therapy (326)
Clinical research (68081)
Collaboration (531)
Compensation (276)
COVID-19 (2740)
C-suite (122)
Data (1433)
Diabetes (192)
Diagnostics (6645)
Earnings (79350)
Employer resources (156)
Events (120797)
Executive appointments (425)
FDA (17818)
Funding (470)
Gene therapy (226)
GLP-1 (699)
Government (4860)
Healthcare (20644)
Infectious disease (2837)
Inflammatory bowel disease (126)
Interviews (658)
IPO (17000)
Job creations (4184)
Job search strategy (2414)
Layoffs (477)
Legal (8039)
Lung cancer (222)
Manufacturing (237)
Medical device (14278)
Medtech (14283)
Mergers & acquisitions (19150)
Metabolic disorders (519)
Neuroscience (1723)
NextGen Class of 2024 (7537)
Non-profit (5046)
Northern California (1769)
Obesity (293)
Opinion (248)
Patents (131)
People (59236)
Pharmaceutical (148)
Phase I (21187)
Phase II (29752)
Phase III (22397)
Pipeline (533)
Postmarket research (2957)
Preclinical (9433)
Radiopharmaceuticals (258)
Rare diseases (295)
Real estate (6689)
Regulatory (23693)
Research institute (2626)
Resumes & cover letters (552)
Southern California (1529)
Startups (3829)
United States (16519)
Vaccines (631)
Weight loss (226)
Date
Last 7 days (191)
Last 30 days (1714)
Last 365 days (36991)
2025 (109)
2024 (37772)
2023 (42407)
2022 (53546)
2021 (58404)
2020 (57459)
2019 (51071)
2018 (38697)
2017 (35243)
2016 (35189)
2015 (40868)
2014 (34600)
2013 (32354)
2012 (31564)
2011 (31820)
2010 (30406)
Location
Africa (1043)
Arizona (175)
Asia (43762)
Australia (7897)
California (4094)
Canada (1485)
China (342)
Colorado (185)
Connecticut (205)
Europe (101893)
Florida (564)
Georgia (146)
Illinois (459)
Indiana (247)
Maryland (696)
Massachusetts (3264)
Michigan (197)
Minnesota (321)
New Jersey (1179)
New York (1150)
North Carolina (885)
Northern California (1769)
Ohio (158)
Pennsylvania (969)
South America (1407)
Southern California (1529)
Texas (599)
Utah (115)
Washington State (446)
748,716 Results for "the new york stem cell foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis
December 19, 2024
·
2 min read
Drug Development
First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients
The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy.
June 5, 2024
·
4 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Press Releases
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Multiple Sclerosis
October 31, 2024
·
2 min read
Press Releases
Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
October 1, 2024
·
3 min read
BioForest
Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference
Indapta Therapeutics, Inc. announced that CEO Mark Frohlich, MD, will be giving a plenary talk today titled, “g-NK cells for the treatment of cancer and autoimmune disease” at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference.
May 23, 2024
·
3 min read
Pharm Country
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after Stem Cell Transplantation
New research in the June 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights a promising approach for alleviating distress, enhancing quality of life, improving physical function, and reducing fatigue in patients with blood cancers who undergo hematopoietic stem cell transplantation.
June 11, 2024
·
5 min read
Press Releases
Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant
December 18, 2024
·
9 min read
Drug Development
Hope Biosciences Research Foundation Announces Topline Results of Cell Therapy Clinical Trial in Long COVID
Houston-area clinical research organization Hope Biosciences Research Foundation shares topline results of a randomized, placebo-controlled Phase II study to evaluate Hope Biosciences’ adipose‑derived allogeneic mesenchymal stem cell therapy for patients with Post‑COVID‑19 syndrome.
May 31, 2024
·
2 min read
Press Releases
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
November 6, 2024
·
5 min read
1 of 74,872
Next
